Clinicians

How Luna works

Luna is sleep-only automation. It adds CGM-guided insulin delivery overnight to the patient’s existing injection regimen.

A clinician in scrubs reviewing papers at a desk with a laptop

Why the night matters most

Our analysis of a trial in adults with type 1 diabetes using insulin pumps estimates that evening-and-overnight closed-loop control delivers over 80% of the glycemic benefit of round-the-clock closed-loop control.1

Those are also the hours with the highest risk. Automating them asks nothing of the patient while they sleep.

Overnight time in range shows what A1c can miss

Time in range is the percentage of time glucose stays between 70 and 180 mg/dL. Unlike A1c, which reflects average glucose over the past two to three months, time in range can be measured for a specific period, like the night.

A patient can hold a reasonable A1c while swinging between overnight lows and morning highs, because an average smooths out exactly the pattern you’d want to see. Overnight time in range measures the window Luna covers.

What we heard from clinicians

In our research with clinicians, three concerns came up again and again about automation for people on injections: the time it takes to start and adjust a system, whether patients who have turned down a pump would ever wear one, and the risk of lows overnight.

Luna is designed around each of them: one input at setup, nothing to wear during the day, and insulin held back when glucose is falling or low.

A man and his clinician looking at a glucose graph on a tablet together

Setup takes one input

Luna needs one setting, entered once: the patient’s typical daily basal dose. There are no basal profiles, carb ratios, or correction factors to set or titrate. The clinical conversation takes about two minutes.

The patient keeps their basal insulin and daytime regimen as prescribed. Luna is filled from their rapid-acting insulin pen and is designed to work with any FDA-cleared iCGM.

Dosing responds to CGM trend

Luna reads the patient’s own CGM and delivers small boluses of rapid-acting insulin, in increments as small as 0.1 units, based on the glucose reading and trend. Luna Eclipse®, the fully closed-loop algorithm inside Luna, determines each dose.

Throughout the night, Luna also monitors for drift in delivery and responds to it. Luna does not deliver meal or daytime correction boluses.

Lows and sensor loss stop delivery

HypoShield™ is a feature of the Luna Eclipse® algorithm intended to help reduce the chance of overnight hypoglycemia by withholding insulin when glucose is falling or low.

Luna does not deliver insulin without CGM data. If readings are interrupted, delivery stops until they resume. The patient's basal insulin is unaffected.

Sources

  1. Luna Health analysis of Kovatchev BP, Kollar L, Anderson SM, et al. Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial. Lancet Digit Health. 2020;2(2):e64–e73. doi:10.1016/S2589-7500(19)30218-3.
A new chapter for overnight

Be the first to know when Luna launches

Luna is not yet available. We’ll let you know when there’s news.

Sign up for updates